Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol)

NCT ID: NCT04213365

Last Updated: 2022-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-24

Study Completion Date

2022-02-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigator general objective is therefore to study and compare the benefit of several methods of management of cognitive difficulties reported by patients during treatment for breast cancer, among several treatments, offered independently in patients' homes and supervised from a distance: adapted physical activity only, cognitive stimulation only, and adapted physical activity coupled with cognitive stimulation (during separate sessions). The study will therefore be the first to include a group benefiting from these two management methods, which will make it possible to assess the individual benefit of cognitive stimulation sessions and adapted physical activity but also the benefit of combined sessions.As this type of combined management has never been the subject of a study, and previous studies relating to a single type of management having raised patient adhesion difficulties, it does not seem certain that this type of care is feasible in practice. Before studying its effectiveness, it is therefore essential to check the feasibility and acceptability of such a program combining sessions of adapted physical activity and cognitive stimulation sessions.Investigator will therefore first carry out a feasibility study, longitudinal and monocentric, which will assess the adherence of patients treated for breast cancer to the performance of cognitive stimulation sessions coupled with sessions of adapted physical activity.This feasibility study is a key stage of the Cog-Stim protocol because its results will probably highlight the obstacles to the intervention program, which will allow the investigator to propose adjustments to improve the study design for the following stages of the protocol. (design optimization).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cognitive stimulation and adapted physical activity

12 weeks of cognitive stimulation sessions coupled with APA (Adapted Physical Activity) sessions.

Group Type OTHER

Cognitive stimulation sessions coupled with Adapted Physical Activity sessions.

Intervention Type OTHER

12 weeks of cognitive stimulation sessions coupled with APA (Adapted Physical Activity) sessions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive stimulation sessions coupled with Adapted Physical Activity sessions.

12 weeks of cognitive stimulation sessions coupled with APA (Adapted Physical Activity) sessions.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged over 18,
* Patient with localized breast cancer, starting or receiving adjuvant radiotherapy , having or not receiving previous adjuvant chemotherapy, not yet having started hormone therapy,
* Patient with a cognitive complaint having a significant impact on her quality of life (FACT
* Cog questionnaire, QoL score ≤ percentile 10 by age),
* Absence of major cognitive impairment preventing the performance of cognitive tests (compliance with the MoCA score threshold according to the age and educational level of the patient according to GRECOGVASC standards)
* Absence of personality disorders and known progressive psychiatric pathology (e.g. schizophrenia),
* Absence of symptomatic neurological history (neurological sequelae of a head trauma, stroke with loss of consciousness\> 30 min, multiple sclerosis, epilepsy, neurodegenerative pathology, etc.),
* Patient with level of education 3 "end of primary education" minimum (Barbizet scale),
* Have access to a computer (fixed or portable) equipped with a keyboard, a webcam (or the possibility of connecting one), headphones or speakers; have an internet connection and an e-mail account; be able to use these tools and Equipment,
* Mastery of the French language,
* Patient who signed the consent to participate in the study.
* Patients should start the study during radiation therapy.

Exclusion Criteria

* Abuse of alcohol or drug use,
* Severe visual and / or hearing loss,
* Patient unable to respond to cognitive tests,
* Medical contraindication to the practice of adapted physical activity
* Cognitive management in progress,
* Patient's refusal to participate,
* Patient deprived of liberty or under guardianship,
* Patient unable to submit to study monitoring for geographic, social or psychopathological reasons.
Minimum Eligible Age

18 Months

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute, France

OTHER_GOV

Sponsor Role collaborator

Ligue contre le cancer, France

OTHER

Sponsor Role collaborator

Centre Francois Baclesse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

centre François Baclesse

Caen, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Binarelli G, Joly F, Christy F, Clarisse B, Lange M. Digital multimodal intervention for cancer-related cognitive impairment in breast-cancer patients: Cog-Stim feasibility study. BMC Psychiatry. 2025 Mar 17;25(1):249. doi: 10.1186/s12888-025-06630-9.

Reference Type DERIVED
PMID: 40098149 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-A02500-57

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.